The Delhi High Court had stated that it would be necessary to ascertain the availability of the two vaccinations in use in India i.e. COVISHIELD and COVAXIN, and also proceeded to issue a notice to Serum Institute of India and Bharat Biotech.
On Wednesday, the Delhi High Court has registered a Suo Motu Oil or the Public Interest Litigation case concerning COVID-19 vaccination of judges, court staff, and lawyers on the top of the priority.
The Public Interest Litigation which was registered in view of a letter written by the Chairman, Bar Council of Delhi, by requesting that appropriate directions be issued to the concerned administrative/ medical authorities to make available necessary infrastructure in the Court premises for vaccination of the members of the judicial system, by treating them as frontline workers.
The Bench of Delhi High Court hearing this case comprises Justice Vipin Sanghi and Justice Rekha and the orders passed by the Justices said that there is weight in the claim made by the Bar Council of Delhi for declaring persons associated with judicial functioning as frontline workers.
They are not found to be suffering from one of the co-morbidities , even if, it does not mean that the risk of their contracting the diseases and suffering serious health issues- which includes fatality, does not exist, the Delhi High Court added further.
The Delhi High Court, later on, ordered, “ To examine the aforesaid aspects, we are inclined to register this communication of Mr. Ramesh Gupta, Bar Council of Delhi dated 01.03.2021 as a Public Interest Litigation.”
The Court concerned further stated that it would be necessary to ascertain the availability of the two vaccination in use in India that are COVISHIELD and COVAXIN, and further processed to issue a notice to its manufacturers, Serum Institute of India and Bharat Biotech.